A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

ID#: NCT03941379

Age: 18 years - 66+

Gender: All

Healthy Subjects: No

Recruitment Status: Recruiting

Start Date: March 27, 2019

End Date: December 01, 2029

Contact Information:
Medical Monitor
617-500-8864
Medical Monitor
Summary: The purpose of this observational research study is to follow participants who have been treated with either bel-sar or received alternate treatment (sham, standard of care therapy, etc.) while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness in these subjects. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.
Eligibility:

Inclusion Criteria:

- Have been clinically diagnosed with primary IL or CM at the time of entry to a previous Aura Biosciences sponsored clinical trial.

- Have received AU-011 bel-sar or assigned to a different cohort or treatment arm (sham, SoC, etc.) an observation cohort in a previous Aura sponsored clinical trial.

Exclusion Criteria:

- None
Find a Clinical Trial Find Cancer Clinical Trials